CD8A and cancer: In contrast, patients with negative HLA-DR tended to show a lower number of CD8-positive, TIA-1-positive T cells, or excluded or desert infiltration patterns, and did not respond to ICI therapy, suggesting an impaired cancer immunity cycle in these patients.